(Q44398329)

2 December 2017

Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children (English)

1 reference

2 December 2017

1 reference

1 reference

Guido Filler

1

1 reference

2 December 2017

Miriam Hansen

2

1 reference

2 December 2017

Claire LeBlanc

3

1 reference

2 December 2017

Nathalie Lepage

4

1 reference

2 December 2017

Doris Franke

5

1 reference

2 December 2017

Ingrid Mai

6

1 reference

2 December 2017

Janusz Feber

7

1 reference

2 December 2017

8 April 2003

1 reference

2 December 2017

1 reference

2 December 2017

18

1 reference

2 December 2017

5

1 reference

2 December 2017

445-449

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-003-1133-1

2 December 2017

0 references

cites work

Optimum sample times for single-injection, multisample renal clearance methods

1 reference

12 December 2020

Mycophenolate mofetil (RS 61443): nothing new under the sun or an important break-through in the field of transplantation?

1 reference

12 December 2020

Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression.

1 reference

12 December 2020

Mycophenolate mofetil for systemic vasculitis and IgA nephropathy

1 reference

12 December 2020

Mycophenolate mofetil for rescue therapy in acute renal transplant rejection in children should always be monitored by measurement of trough concentration

1 reference

12 December 2020

Lupus nephritis in children

1 reference

12 December 2020

Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration

1 reference

12 December 2020

Predictors of flares and long-term outcome of systemic lupus erythematosus during combined treatment with azathioprine and low-dose prednisolone

1 reference

12 December 2020

Toxic effects of immunosuppressive drugs: mechanisms and strategies for controlling them.

1 reference

12 December 2020

Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus

1 reference

12 December 2020

Glomerular filtration rate estimated from the uptake phase of 99mTc-DTPA renography in chronic renal failure

1 reference

12 December 2020

Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites

1 reference

12 December 2020

Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients

1 reference

12 December 2020

Estimation of Glomerular Filtration Rate from Plasma Clearance of 51-Chromium Edetic Acid

1 reference

12 December 2020

An overview of the treatment of childhood SLE.

1 reference

12 December 2020

Diagnostic sensitivity of serum cystatin for impaired glomerular filtration rate.

1 reference

12 December 2020

Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide.

1 reference

12 December 2020

Estimation of glomerular filtration rate using chromium-51 ethylene diamine tetra-acetic acid and technetium-99m diethylene triamine penta-acetic acid

1 reference

12 December 2020

Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus.

1 reference

12 December 2020

The safety and efficacy of MMF in lupus nephritis: a pilot study

1 reference

12 December 2020

Attenuation of murine lupus nephritis by mycophenolate mofetil.

1 reference

12 December 2020

10.1007/S00467-003-1133-1

Identifiers

DOI

0 references

1 reference